Ignite Creation Date:
2024-05-05 @ 7:32 PM
Last Modification Date:
2024-10-26 @ 9:51 AM
Study NCT ID:
NCT00698906
Status:
COMPLETED
Last Update Posted:
2008-06-17
First Post:
2008-06-13
Brief Title:
Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix-B in Adults Aged 19-40 y
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline